Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol - PubMed (original) (raw)
Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol
S Saji et al. Jpn J Cancer Res. 1999 Feb.
Abstract
The overexpression of the oncogene product MDM2 is often observed in human breast cancer cells, especially in estrogen receptor (ER)-positive ones. To study the role of MDM2 protein in ER-positive breast cancer, we have established cell lines derived from MCF-7 which stably express increased and decreased levels of MDM2 by transfection of a mammalian expression vector containing human mdm2 cDNA in sense and antisense orientations, respectively. Interestingly, MDM2 overexpression in MCF-7 cells afforded a remarkable growth advantage under estradiol (E2)-supplemented condition. Then, we analyzed the expression of p53, which is an important regulator of growth and the cell cycle. Unexpectedly, the p53 accumulation induced by E2 was remarkably higher in MCF-7 cells stably overexpressing MDM2 than in the parent MCF-7 cells. On the other hand, reduction of MDM2 suppressed the E2-induced increase in p53 protein. Moreover, mdm2 antisense oligonucleotides prevented E2-induced accumulation of p53. In the steady state, the cellular levels of p53 were also correlated with those of MDM2. These interactions are not consistent with the well-known role of MDM2, which acts as a negative regulator for p53 by inhibiting its function and promoting its rapid degradation. These results suggest that MDM2 may regulate the expression of p53 in the steady state and in response to E2 in breast cancer cells, and imply a novel and important role of MDM2 during breast carcinogenesis.
Similar articles
- Estradiol stabilizes p53 protein in breast cancer cell line, MCF-7.
Okumura N, Saji S, Eguchi H, Hayashi S, Saji S, Nakashima S. Okumura N, et al. Jpn J Cancer Res. 2002 Aug;93(8):867-73. doi: 10.1111/j.1349-7006.2002.tb01331.x. Jpn J Cancer Res. 2002. PMID: 12716463 Free PMC article. - MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells.
Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S, Hayashi S. Saji S, et al. Biochem Biophys Res Commun. 2001 Feb 16;281(1):259-65. doi: 10.1006/bbrc.2001.4339. Biochem Biophys Res Commun. 2001. PMID: 11178989 - The p53-binding protein MDM2 gene is differentially expressed in human breast carcinoma.
Sheikh MS, Shao ZM, Hussain A, Fontana JA. Sheikh MS, et al. Cancer Res. 1993 Jul 15;53(14):3226-8. Cancer Res. 1993. PMID: 8324731 - Mdm2: keeping p53 under control.
Piette J, Neel H, Maréchal V. Piette J, et al. Oncogene. 1997 Aug 28;15(9):1001-10. doi: 10.1038/sj.onc.1201432. Oncogene. 1997. PMID: 9285554 Review. - The mdm2 proto-oncogene.
Haines DS. Haines DS. Leuk Lymphoma. 1997 Jul;26(3-4):227-38. doi: 10.3109/10428199709051772. Leuk Lymphoma. 1997. PMID: 9322885 Review.
Cited by
- Cytotoxicity, crosslinking and biological activity of three mitomycins.
Cheng SY, Delgado-Cruzata L, Clement CC, Zacarias O, Concheiro-Guisan M, Towler N, Snyder T, Zheng M, Almodovar N, Gonzalez C, Romaine M, Sapse AM, Champeil E. Cheng SY, et al. Bioorg Chem. 2022 Jun;123:105744. doi: 10.1016/j.bioorg.2022.105744. Epub 2022 Mar 22. Bioorg Chem. 2022. PMID: 35349830 Free PMC article. - CMIP is oncogenic in human gastric cancer cells.
Zhang J, Huang J, Wang X, Chen W, Tang Q, Fang M, Qian Y. Zhang J, et al. Mol Med Rep. 2017 Nov;16(5):7277-7286. doi: 10.3892/mmr.2017.7541. Epub 2017 Sep 20. Mol Med Rep. 2017. PMID: 28944848 Free PMC article. - Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.
Deisenroth C, Thorner AR, Enomoto T, Perou CM, Zhang Y. Deisenroth C, et al. Mol Cell Biol. 2010 Aug;30(16):3981-93. doi: 10.1128/MCB.01284-09. Epub 2010 Jun 14. Mol Cell Biol. 2010. PMID: 20547751 Free PMC article. - Recent advances in validating MDM2 as a cancer target.
Rayburn ER, Ezell SJ, Zhang R. Rayburn ER, et al. Anticancer Agents Med Chem. 2009 Oct;9(8):882-903. doi: 10.2174/187152009789124628. Anticancer Agents Med Chem. 2009. PMID: 19538162 Free PMC article. Review. - Estradiol stabilizes p53 protein in breast cancer cell line, MCF-7.
Okumura N, Saji S, Eguchi H, Hayashi S, Saji S, Nakashima S. Okumura N, et al. Jpn J Cancer Res. 2002 Aug;93(8):867-73. doi: 10.1111/j.1349-7006.2002.tb01331.x. Jpn J Cancer Res. 2002. PMID: 12716463 Free PMC article.
References
- ) Cahilly‐Snyder , L. , Yang‐Feng , T. , Francke , U. and George , D. L.Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line . Somat. Cell Mol. Genet. , 13 , 235 – 244 ( 1987. ). - PubMed
- ) Oliner , J. D. , Kinzler , K. W. , Meltzer , P. S. , George , D. L. and Vogelstein , B.Amplification of a gene encoding a p53‐associated protein in human sarcomas . Nature , 358 , 80 – 83 ( 1992. ). - PubMed
- ) Momand , J. , Zambetti , G. P. , Olson , D. C. , George , D. and Levine , A. J.The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53–mediated trans‐activation . Cell , 69 , 1237 – 1245 ( 1992. ). - PubMed
- ) Kussie , P. H. , Gorina , S. , Marechal , V. , Elenbaas , B. , Moreau , J. , Levine , A. J. and Pavletich , N. P.Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain . Science , 274 , 948 – 953 ( 1996. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous